Dynamic changes in pathology and PD‐L1 expression in a patient with metastatic lung adenocarcinoma who received pembrolizumab therapy followed by two salvage surgeries two years later: A case report

During chemotherapy, certain cancer cells undergo cell death, which alters the properties of remaining cells and leads to numerous changes in the constituent cells of lung cancer. Immunotherapy has been used as neoadjuvant therapy, and several studies have reported changes in lung cancer tissue foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Green, Park, Hee Sun, Yeo, Min Kyung, Lee, Dahye, Chung, Chaeuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423660/
https://www.ncbi.nlm.nih.gov/pubmed/37416998
http://dx.doi.org/10.1111/1759-7714.15023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423660/
https://www.ncbi.nlm.nih.gov/pubmed/37416998
http://dx.doi.org/10.1111/1759-7714.15023

Ejemplares similares